Christopher Cargile Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Christopher Cargile's research focuses on the pharmacological effects of various substances in humans, particularly in the context of opioid-related disorders. His work investigates the dose-response relationships of drugs like methadone, gabapentin, and D-cycloserine, often examining their interactions with opioid antagonists such as naloxone. Cargile has published on these topics, including recent work in 2025 exploring the combined effects of gabapentin, D-cycloserine, and naloxone in individuals maintained on methadone. His scholarship metrics include an h-index of 7, with 13 total publications and 251 citations. Cargile collaborates with researchers at the University of Arkansas for Medical Sciences, including Michael J. Mancino, Alison Oliveto, J. Benjamin Guise, and Lauren R. Fitzgerald, with whom he shares publications.
Metrics
- h-index: 7
- Publications: 13
- Citations: 251
Selected Publications
-
Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure (2025)
Grants & Funding
Collaboration Network
Top Collaborators
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
Similar Researchers
Based on overlapping research topics